United Kingdom (UK) Next Generation Cancer Diagnostics Market (2025-2031) | Size & Revenue, Segmentation, Share, Outlook, Growth, Trends, Industry, Forecast, Competitive Landscape, Analysis, Value, Companies

Market Forecast By Technology (Next-generation Sequencing, qPCR & Multiplexing, Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), Protein Microarrays, DNA Microarrays), By Application (Biomarker Development, CTC Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), By Cancer (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), By Function (Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis) And Competitive Landscape
Product Code: ETC9949818 Publication Date: Sep 2024 Updated Date: Jan 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United Kingdom (UK) Next Generation Cancer Diagnostics Market Outlook
  • Market Size of United Kingdom (UK) Next Generation Cancer Diagnostics Market, 2024
  • Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market, 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Revenues & Volume for the Period 2021- 2031
  • United Kingdom (UK) Next Generation Cancer Diagnostics Market Trend Evolution
  • United Kingdom (UK) Next Generation Cancer Diagnostics Market Drivers and Challenges
  • United Kingdom (UK) Next Generation Cancer Diagnostics Price Trends
  • United Kingdom (UK) Next Generation Cancer Diagnostics Porter's Five Forces
  • United Kingdom (UK) Next Generation Cancer Diagnostics Industry Life Cycle
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By Technology for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By Next-generation Sequencing for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By qPCR & Multiplexing for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR) for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By Protein Microarrays for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By DNA Microarrays for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By Application for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By Biomarker Development for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By CTC Analysis for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By Proteomic Analysis for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By Epigenetic Analysis for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By Genetic Analysis for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By Lung Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By Breast Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By Colorectal Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By Cervical Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By Function for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By Therapeutic Monitoring for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By Companion Diagnostics for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By Prognostics for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By Cancer Screening for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume By Risk Analysis for the Period 2021- 2031
  • United Kingdom (UK) Next Generation Cancer Diagnostics Import Export Trade Statistics
  • Market Opportunity Assessment By Technology
  • Market Opportunity Assessment By Application
  • Market Opportunity Assessment By Cancer
  • Market Opportunity Assessment By Function
  • United Kingdom (UK) Next Generation Cancer Diagnostics Top Companies Market Share
  • United Kingdom (UK) Next Generation Cancer Diagnostics Competitive Benchmarking By Technical and Operational Parameters
  • United Kingdom (UK) Next Generation Cancer Diagnostics Company Profiles
  • United Kingdom (UK) Next Generation Cancer Diagnostics Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United Kingdom (UK) Next Generation Cancer Diagnostics Market Overview

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Next Generation Cancer Diagnostics Market - Industry Life Cycle

3.4 United Kingdom (UK) Next Generation Cancer Diagnostics Market - Porter's Five Forces

3.5 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Cancer, 2021 & 2031F

3.8 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Function, 2021 & 2031F

4 United Kingdom (UK) Next Generation Cancer Diagnostics Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 United Kingdom (UK) Next Generation Cancer Diagnostics Market Trends

6 United Kingdom (UK) Next Generation Cancer Diagnostics Market, By Types

6.1 United Kingdom (UK) Next Generation Cancer Diagnostics Market, By Technology

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume, By Next-generation Sequencing, 2021- 2031F

6.1.4 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume, By qPCR & Multiplexing, 2021- 2031F

6.1.5 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume, By Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), 2021- 2031F

6.1.6 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume, By Protein Microarrays, 2021- 2031F

6.1.7 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume, By DNA Microarrays, 2021- 2031F

6.2 United Kingdom (UK) Next Generation Cancer Diagnostics Market, By Application

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume, By Biomarker Development, 2021- 2031F

6.2.3 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume, By CTC Analysis, 2021- 2031F

6.2.4 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume, By Proteomic Analysis, 2021- 2031F

6.2.5 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume, By Epigenetic Analysis, 2021- 2031F

6.2.6 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume, By Genetic Analysis, 2021- 2031F

6.3 United Kingdom (UK) Next Generation Cancer Diagnostics Market, By Cancer

6.3.1 Overview and Analysis

6.3.2 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume, By Lung Cancer, 2021- 2031F

6.3.3 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.3.4 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F

6.3.5 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume, By Cervical Cancer, 2021- 2031F

6.3.6 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F

6.4 United Kingdom (UK) Next Generation Cancer Diagnostics Market, By Function

6.4.1 Overview and Analysis

6.4.2 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume, By Therapeutic Monitoring, 2021- 2031F

6.4.3 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F

6.4.4 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume, By Prognostics, 2021- 2031F

6.4.5 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume, By Cancer Screening, 2021- 2031F

6.4.6 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenues & Volume, By Risk Analysis, 2021- 2031F

7 United Kingdom (UK) Next Generation Cancer Diagnostics Market Import-Export Trade Statistics

7.1 United Kingdom (UK) Next Generation Cancer Diagnostics Market Export to Major Countries

7.2 United Kingdom (UK) Next Generation Cancer Diagnostics Market Imports from Major Countries

8 United Kingdom (UK) Next Generation Cancer Diagnostics Market Key Performance Indicators

9 United Kingdom (UK) Next Generation Cancer Diagnostics Market - Opportunity Assessment

9.1 United Kingdom (UK) Next Generation Cancer Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 United Kingdom (UK) Next Generation Cancer Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 United Kingdom (UK) Next Generation Cancer Diagnostics Market Opportunity Assessment, By Cancer, 2021 & 2031F

9.4 United Kingdom (UK) Next Generation Cancer Diagnostics Market Opportunity Assessment, By Function, 2021 & 2031F

10 United Kingdom (UK) Next Generation Cancer Diagnostics Market - Competitive Landscape

10.1 United Kingdom (UK) Next Generation Cancer Diagnostics Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Next Generation Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All